- What is Immunome, Inc.’s (IMNM) StockRank?
- MoatMap’s StockRank for Immunome, Inc. (IMNM) is 42/100, with a Hold signal. It is a composite of Quality (34), Value (34), and Momentum (61) factor ranks across MoatMap’s 19,000+ stock universe.
- Does Immunome, Inc. have an economic moat?
- Immunome, Inc. (IMNM) has a Quality factor score of 34/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
- Is Immunome, Inc. a buy, hold, or sell?
- MoatMap’s current signal for Immunome, Inc. (IMNM) is Hold, based on a StockRank of 42/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
- What sector is Immunome, Inc. in?
- Immunome, Inc. (IMNM) operates in the Healthcare sector, specifically the Biotechnology industry (United States).